A Head CT is Unnecessary in the Initial Evaluation of A Cirrhotic Patient with Recurrent Hepatic Encephalopathy

Sumit Kumar1, Ronak Modi2, Bhavik M Bhandari2

  • 1Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Sidney Kimmel Medical College, Philadelphia, Pennsylvania, USA.

Annals of Hepatology
|August 27, 2018
PubMed

Insights

Head CT scans rarely identify intracranial causes of hepatic encephalopathy in cirrhotic patients. This study found a low yield for head CTs in evaluating altered mental status in these patients.

Area of Science:

  • Hepatology
  • Neurology
  • Radiology

Background:

  • Hepatic encephalopathy (HE) is a common complication in patients with cirrhosis.
  • Evaluation for HE typically involves laboratory tests to exclude infections and metabolic derangements.
  • Head CT scans are often used empirically in cirrhotic patients with recurrent HE, despite limited evidence.

Purpose of the Study:

  • To determine the diagnostic yield of head CT scans in evaluating the cause of hepatic encephalopathy in patients with cirrhosis.
  • To assess the prevalence of intracranial findings explaining HE in this patient population.

Main Methods:

  • Retrospective review of medical records of cirrhotic adults admitted between 2007 and 2010.
  • Analysis of 147 episodes of hepatic encephalopathy where head CT was performed.
  • Correlation of CT findings with patient history (trauma) and neurological examination.

Main Results:

  • Only 4% of head CTs (6/147 episodes) revealed intracranial findings explaining hepatic encephalopathy.
  • The prevalence of intracranial findings was 0.6% (1/142) in the absence of trauma or focal neurological signs.
  • Clinical and laboratory variables did not significantly predict head CT findings.

Conclusions:

  • Head CT scans have a very low diagnostic yield for identifying the cause of altered mental status in cirrhotic patients with recurrent hepatic encephalopathy.
  • Routine head CTs are not recommended as an initial evaluation tool for HE in this population.
Abstract

Related Concept Videos

Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.0K
Initiation of Translation02:33

Initiation of Translation

8.1K
Transcription Initiation01:47

Transcription Initiation

Initiation is the first step of transcription in eukaryotes. Prokaryotic RNA Polymerase (RNAP) can bind to the template DNA and start transcribing. On the other hand, transcription in eukaryotes requires additional proteins, called transcription factors, to first bind to the promoter region in the DNA template. This binding helps recruit the specific RNAP that can assemble on the DNA and start transcription.
The promoters and enhancers and their accessory proteins allow tight regulation of...
21.2K
Muscles that Move the Head01:19

Muscles that Move the Head

The muscles that move the head are a dynamic and complex group of structures that work together to facilitate a wide range of head movements, including rotation, flexion, extension, and lateral bending.
The bilateral sternocleidomastoid, or SCM, and the suprahyoid and infrahyoid muscles are significant head flexors. The SCM muscles originate at the sternum and clavicle and attach to the mastoid process of the temporal bone. The SCM contracts bilaterally to bend the head forward, whereas...
6.0K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.0K